Pulse Biosciences, Inc.
PLSE
$20.99
$0.060.26%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 206.98% | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 206.98% | -- | |||
| Cost of Revenue | -6.81% | -- | |||
| Gross Profit | 102.07% | -- | |||
| SG&A Expenses | -16.52% | 7.26% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -9.47% | 0.88% | |||
| Operating Income | 10.38% | -0.45% | |||
| Income Before Tax | 10.07% | -1.13% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 10.07% | -1.13% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 10.07% | -1.13% | |||
| EBIT | 10.38% | -0.45% | |||
| EBITDA | 10.53% | -0.54% | |||
| EPS Basic | 10.60% | -0.98% | |||
| Normalized Basic EPS | 10.62% | -0.95% | |||
| EPS Diluted | 10.60% | -0.98% | |||
| Normalized Diluted EPS | 10.62% | -0.95% | |||
| Average Basic Shares Outstanding | 0.60% | 0.16% | |||
| Average Diluted Shares Outstanding | 0.60% | 0.16% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||